NS1

NS1

NS1 Overview

Molecule Name
Src homology phosphotyrosyl phosphatase 2
Synonyms
NS1
Drug Development Progress
Drugs in Clinical Trials20
Approved Drugs0
Highest Development StagePhase 3 Clinical
Target Synonym
Protein Tyrosine Phosphatase Non-Receptor Type 11,SHP-2,PTP2C,Protein-tyrosine phosphatase 2C,PTP-2C,PTP-1D,SH-PTP3,PTPN11,Protein-Tyrosine Phosphatase 1D,SH-PTP2,EC:3.1.3.48,Noonan Syndrome 1,EC 3.1.3.48,METCDS,SHPTP2,BPTP3,JMML,SHP2,CFC,NS1,Protein Tyrosine Phosphatase, Non-Receptor Type 11,Tyrosine-Protein Phosphatase Non-Receptor Type 11
Background
Zika virus (ZIKV) is a member of the virus family Flaviviridae and the genus Flavivirus, transmitted by daytime-active Aedes mosquitoes, such as A. aegypti and A. albopictus. Its name comes from the Zika Forest of Uganda, where the virus was first isolated in 1947. Zika virus is related to dengue, yellow fever, Japanese encephalitis, and West Nile viruses. The infection, known as Zika fever, often causes no or only mild symptoms, similar to a mild form of dengue fever. It is treated by rest. Since the 1950s, it has been known to occur within a narrow equatorial belt from Africa to Asia. As of 2016, the illness cannot be prevented by drugs or vaccines. As of February 2016, there is evidence that Zika fever in pregnant women is associated with abnormal brain development in their fetuses through mother-to-child transmission of the virus, which may result in miscarriage or microcephaly.

Product Inquiry

Clinical Drug Information

English NameResearch CodeHighest Development StageCompanyIndicationClinical Trial
JAB-3312JAB-3312Phase 3 ClinicalJacobio Pharmaceuticals Co Ltd
Solid tumours; Squamous Cell Carcinoma of Head and Neck; Breast Neoplasms; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung
Details
JAB-3068JAB-3068Phase 2 ClinicalJacobio Pharmaceuticals Co Ltd, Abbvie Inc
Solid tumours; Head and Neck Neoplasms; Esophageal Neoplasms; Squamous Cell Carcinoma of Head and Neck; Carcinoma, Adenoid Cystic; Esophageal Squamous Cell Carcinoma; Lymphoma; Carcinoma, Non-Small-Cell Lung
Details
VociprotafibRMC-4630; SAR-442720Phase 2 ClinicalSanofi, Revolution Medicines Inc
Solid tumours; Neoplasms; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis
Details
BatoprotafibTNO-155Phase 2 ClinicalNovartis Pharma Ag
Solid tumours; Squamous Cell Carcinoma of Head and Neck; Renal Insufficiency; Neoplasms; Colorectal Neoplasms; Gastrointestinal Stromal Tumors; Hepatic Insufficiency; Lung Neoplasms; Esophageal Squamous Cell Carcinoma; Carcinoma, Non-Small-Cell Lung; Neoplasm Metastasis; Melanoma
Details
GH-21GH 21005; GH-21; HBI-2376Phase 2 ClinicalSuzhou GenHouse pharmaceutical Co Ltd
Solid tumours; Head and Neck Neoplasms; Colonic Neoplasms; Pancreatic Neoplasms; Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
BR-790BR-790Phase 2 ClinicalJiangxi Qingfeng Pharmaceutical Industry Co Ltd
Solid tumours; Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
BBP-398IACS-15509; BBP-398; IACS-13909; BMS-986466Phase 2 ClinicalBridgebio Pharma Inc, The University Of Texas MD Anderson Cancer Center
Solid tumours; Carcinoma, Non-Small-Cell Lung
Details
MigoprotafibRLY-1971; GDC-1971; RO-7517834; RG-6433Phase 1 ClinicalRelay Therapeutics Inc
Solid tumours; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
A-380A-380Phase 1 ClinicalShandong Kelun Phaemaceutical Co Ltd, Klus Pharma Inc
Neoplasms
Details
KYHY-2303KYHY2303; KYHY-2303Phase 1 ClinicalJiangsu Kanion Pharmaceutical Co Ltd, Shanghai Institute Of Materia Medica, Chinese Academy Of Sciences
Hematologic Neoplasms
Details
RG-001RG001; RG-001Phase 1 ClinicalShanghai Lingji Biological Technology Co Ltd
Neoplasms
Details
HS-336HS336; HS-336Phase 1 ClinicalZhejiang Hisun Pharmaceutical Co Ltd
Solid tumours
Details
HMPL-415S1HMPL-415S1Phase 1 ClinicalHutchison Medipharma Ltd
Solid tumours
Details
BPI-442096Phase 1 ClinicalBetta Pharmaceuticals Co Ltd
Solid tumours; Pancreatic Neoplasms; Colorectal Neoplasms; Carcinoma, Non-Small-Cell Lung
Details
HS-10381HS-10381Phase 1 ClinicalJiangsu Hansoh Pharmaceutical Group Co Ltd
Solid tumours
Details
ET-0038ET-0038Phase 1 ClinicalShanghai Yituo Pharmaceutical Technology Co Ltd
Solid tumours
Details
PF-07284892ARRY-558; PF-07284892Phase 1 ClinicalPfizer Inc
Solid tumours; Colorectal Neoplasms; Carcinoma, Pancreatic Ductal; Carcinoma, Non-Small-Cell Lung
Details
ICP-189ICP-189Phase 1 ClinicalInnoCare Pharma Ltd
Solid tumours; Carcinoma, Non-Small-Cell Lung
Details
ERAS-601ERAS-601Phase 1 ClinicalErasca Inc
Solid tumours; Leukemia, Myeloid, Acute
Details
SH-3809SH3809Phase 1 ClinicalNanjing Sanhome Pharmaceutical Co Ltd
Solid tumours
Details